183 related articles for article (PubMed ID: 28421723)
1. Clinical Outcomes of Proton Beam Therapy for Choroidal Melanoma at a Single Institute in Korea.
Kim TW; Choi E; Park J; Shin DH; Jung SK; Seok S; Cho KH; Kim JY; Kim DY; Kim TH; Suh YK; Kim YJ; Moon SH
Cancer Res Treat; 2018 Apr; 50(2):335-344. PubMed ID: 28421723
[TBL] [Abstract][Full Text] [Related]
2. Visual outcomes of proton beam therapy for choroidal melanoma at a single institute in the Republic of Korea.
Jung SK; Park YH; Shin DH; Kim HS; Jung JH; Kim TH; Moon SH
PLoS One; 2020; 15(12):e0242966. PubMed ID: 33264363
[TBL] [Abstract][Full Text] [Related]
3. Neovascular glaucoma after proton beam therapy of choroidal melanoma: incidence and risk factors.
Riechardt AI; Pilger D; Cordini D; Seibel I; Gundlach E; Hager A; Joussen AM
Graefes Arch Clin Exp Ophthalmol; 2017 Nov; 255(11):2263-2269. PubMed ID: 28721444
[TBL] [Abstract][Full Text] [Related]
4. Ablative dose proton beam therapy for stage I and recurrent non-small cell lung carcinomas : Ablative dose PBT for NSCLC.
Lee SU; Moon SH; Cho KH; Pyo HR; Kim JY; Kim DY; Kim TH; Suh YG; Kim YJ
Strahlenther Onkol; 2016 Sep; 192(9):649-57. PubMed ID: 27282279
[TBL] [Abstract][Full Text] [Related]
5. Outcomes After Proton Beam Therapy for Large Choroidal Melanomas in 492 Patients.
Bensoussan E; Thariat J; Maschi C; Delas J; Schouver ED; Hérault J; Baillif S; Caujolle JP
Am J Ophthalmol; 2016 May; 165():78-87. PubMed ID: 26940166
[TBL] [Abstract][Full Text] [Related]
6. Proton therapy of iris melanoma with 50 CGE : Influence of target volume on clinical outcome.
Riechardt AI; Karle B; Cordini D; Heufelder J; Budach V; Joussen AM; Gollrad J
Strahlenther Onkol; 2017 Nov; 193(11):943-950. PubMed ID: 28631017
[TBL] [Abstract][Full Text] [Related]
7. Proton beam therapy leads to excellent local control rates in choroidal melanoma in the intermediate fundus zone.
Schönfeld S; Cordini D; Riechardt AI; Seibel I; Willerding G; Bechrakis NE; Moser L; Joussen AM
Am J Ophthalmol; 2014 Dec; 158(6):1184-91. PubMed ID: 25128597
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of Patients With Primary Sacral Chordoma Treated With Definitive Proton Beam Therapy.
Aibe N; Demizu Y; Sulaiman NS; Matsuo Y; Mima M; Nagano F; Terashima K; Tokumaru S; Hayakawa T; Suga M; Daimon T; Suzuki G; Hideya Y; Yamada K; Sasaki R; Fuwa N; Okimoto T
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):972-979. PubMed ID: 29485077
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of treatment with stereotactic radiosurgery or proton beam therapy for choroidal melanoma.
Sikuade MJ; Salvi S; Rundle PA; Errington DG; Kacperek A; Rennie IG
Eye (Lond); 2015 Sep; 29(9):1194-8. PubMed ID: 26160531
[TBL] [Abstract][Full Text] [Related]
10. Prospective study of proton-beam radiation therapy for limited-stage small cell lung cancer.
Rwigema JM; Verma V; Lin L; Berman AT; Levin WP; Evans TL; Aggarwal C; Rengan R; Langer C; Cohen RB; Simone CB
Cancer; 2017 Nov; 123(21):4244-4251. PubMed ID: 28678434
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of proton radiation therapy for peripapillary choroidal melanoma at the BC Cancer Agency.
Tran E; Ma R; Paton K; Blackmore E; Pickles T
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1425-31. PubMed ID: 22209152
[TBL] [Abstract][Full Text] [Related]
12. Hypofractionated stereotactic photon radiotherapy of posteriorly located choroidal melanoma with five fractions at ten Gy--clinical results after six years of experience.
Dunavoelgyi R; Zehetmayer M; Gleiss A; Geitzenauer W; Kircher K; Georg D; Schmidt-Erfurth U; Poetter R; Dieckmann K
Radiother Oncol; 2013 Aug; 108(2):342-7. PubMed ID: 24044800
[TBL] [Abstract][Full Text] [Related]
13. Uveal melanoma: quantitative evaluation of diffusion-weighted MR imaging in the response assessment after proton-beam therapy, long-term follow-up.
Foti PV; Longo A; Reibaldi M; Russo A; Privitera G; Spatola C; Raffaele L; Salamone V; Farina R; Palmucci S; Musumeci A; Caltabiano R; Ragusa M; Mariotti C; Avitabile T; Milone P; Ettorre GC
Radiol Med; 2017 Feb; 122(2):131-139. PubMed ID: 27752969
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant Ab Interno Tumor Treatment After Proton Beam Irradiation.
Seibel I; Riechardt AI; Heufelder J; Cordini D; Joussen AM
Am J Ophthalmol; 2017 Jun; 178():94-100. PubMed ID: 28365241
[TBL] [Abstract][Full Text] [Related]
15. Small metastasizing choroidal melanomas.
Malclès A; Kivelä T; Svetlosakova Z; Jean-Louis B; Nguyen AM; Sallit R; Négrier S; Pommier P; Rivoire M; Chauvel P; Mammar H; Devouassoux-Shisheboran M; Kodjikian L; Denis P; Grange JD
Acta Ophthalmol; 2015 Mar; 93(2):e160-6. PubMed ID: 25124923
[TBL] [Abstract][Full Text] [Related]
16. Clinical Outcomes and Prognostic Factors of High-Dose Proton Beam Therapy for Peripheral Stage I Non-Small-Cell Lung Cancer.
Hatayama Y; Nakamura T; Suzuki M; Azami Y; Ono T; Yabuuchi T; Hayashi Y; Kimura K; Hirose K; Wada H; Hareyama M; Kikuchi Y; Takai Y
Clin Lung Cancer; 2016 Sep; 17(5):427-432. PubMed ID: 26725851
[TBL] [Abstract][Full Text] [Related]
17. Proton beam therapy of parapapillary choroidal melanoma.
Riechardt AI; Cordini D; Willerding GD; Georgieva I; Weber A; Seibel I; Lakotka N; Bechrakis NE; Foerster MH; Moser L; Joussen AM
Am J Ophthalmol; 2014 Jun; 157(6):1258-65. PubMed ID: 24548873
[TBL] [Abstract][Full Text] [Related]
18. Salvage proton beam therapy for recurrent iris melanoma: outcome and side effects.
Riechardt AI; Klein JP; Cordini D; Heufelder J; Rehak M; Seibel I; Joussen AM
Graefes Arch Clin Exp Ophthalmol; 2018 Jul; 256(7):1325-1332. PubMed ID: 29464331
[TBL] [Abstract][Full Text] [Related]
19. The clinical results of proton beam therapy in patients with idiopathic pulmonary fibrosis: a single center experience.
Ono T; Hareyama M; Nakamura T; Kimura K; Hayashi Y; Azami Y; Hirose K; Hatayama Y; Suzuki M; Wada H; Kikuchi Y; Nemoto K
Radiat Oncol; 2016 Apr; 11():56. PubMed ID: 27090216
[TBL] [Abstract][Full Text] [Related]
20. Clinical Outcomes of Patients With Unresectable Cholangiocarcinoma Treated With Proton Beam Therapy.
Hung SP; Huang BS; Hsieh CE; Lee CH; Tsang NM; Chang JT; Chen JS; Chou WC; Tseng JH; Hong JH
Am J Clin Oncol; 2020 Mar; 43(3):180-186. PubMed ID: 31764017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]